PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Why "Episodes" Matter for Doctors

It's Time to Get Smarter about Content Management and Document Production

New "Right-to-Try" Law Challenges FDA Oversight

Advertisement
Top Story
Adherence: Addressing Pharma's Last-Mile Problem
Addressing adherence with c-suite sponsorship and at scale has the capacity increase revenue, improve patient outcomes and lower health care costs, writes Tom Kottler
/Read more/
Advertisement
Deloitte's 2018 Life Sciences Accounting & Financial Reporting Update
How can life sciences companies keep pace with emerging accounting and financial reporting challenges? Learn about new accounting standards for revenue recognition, leases, and definition of a business and existing rules for R&D, acquisitions and divestitures, income taxes and more. Our ninth annual report also includes interpretive guidance to help you address these challenges.
Download now
Biotech
Building New York into the Next Biotech Hotspot
Attracting and keeping the scientific breakthroughs in-state is something that's keeping New York economic and academic developers up at night, writes Michelle Maskaly.
/Read more/
Advertisement
Do you know an Emerging Pharma Leader?
Nominate a colleague with impressive leadership and career intentions — even yourself! — for Pharmaceutical Executive's 2018 Emerging Pharma Leaders Awards.
Submit your nomination today!
Special Feature
Pharm Exec's Brands of the Year: Promises and Challenges
In its 12th annual feature, Pharm Exec profiles a new round of biopharma products that are making waves in five key areas in healthcare and R&D
/Read more/
Calendar
/ June 13–14: Connected Devices in Life Sciences /
Boston, MA
/ June 14: GTN Bootcamp for Bioscience Companies /
San Francisco, CA
/ June 19–20: Rare Disease Innovation Summit /
Boston, MA
/ June 21–22: Disruptive Downstream Technologies /
San Diego, CA
/ August 14–15: Publication Planning 2018 /
Philadelphia, PA
/ August 15–16: Reimbursement and Access 2018 /
Philadelphia, PA
/ August 20–22: Transparency and Aggregate Spend 2018 /
Washington, DA, PA
/ October 15–17: 28th Annual Sharing Conference: Compliance /
National Harbor, MD
/ November 13–14: Commercial Data Insights 2018 /
Philadelphia, PA
/ November 13–14: Due Diligence for Life Sciences M&A, Partnerships and Divestitures /
Philadelphia, PA
/ November 14–15: 5th Annual Global Compliance Congress for Life Sciences /
London, UK
/ November 28–29: Compliant Patient Support Programs Summit /
Chicago, IL
/ December 4–5: Managed Markets Compliance Congress 2018 /
Philadelphia, PA
/ December 5–6: Bio/Pharma Compliance Congress on Non-Promotional Activities /
Philadelphia, PA
Advertisement
Advertisement
The world is larger than you think - Don't get lost
Cultural insight the key to doing business in a globalized world. Become a global business insider with Pharma Reports, a series of PDF-format reports detailing the latest market conditions and opportunities in more than 10 countries.
Explore now
Audio
The Pharm Exec Podcast: Brands of the Year
The Pharm Exec editors talk about how and why this year's selections were chosen
/Click here to listen/
Advertisement
Don't let your campaign fall apart
Strategic product management is the glue holding an operation together. This Pharmaceutical Executive handbook is your go-to guide for effective and profitable product management.
Read more
Global
The PD-1/PD-L1 Race in China
Jin Zhang outlines how China's PD-1/PD-L1 market is heating up
/Read more/
Advertisement
Combination Therapies in Oncology: The Benefits of Integrated Insights
Thursday, June 14, 2018 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register now

Industry update
// Collegium Pharmaceutical (Canton, MA) announced that Joseph Ciaffoni, Executive Vice President and Chief Operating Officer, will be promoted to Chief Executive Officer and join the Board of Directors effective July 1, 2018. Mr. Ciaffoni will succeed Michael T. Heffernan, who founded Collegium in 2003 and will step down as CEO on June 30, 2018. Mr. Heffernan will continue to serve as Chairman of the Board. // Codiak BioSciences (Cambridge, MA) appointed Richard Brudnick as Chief Business Officer and Head of Strategy. // Acea Therapeutics (Cambridge, MA), an affiliate of Ionis Pharmaceuticals, announced the appointment of Richard (Rich) A. Moscicki, M.D., to the company's Board of Directors. // Strategic Consulting (Baltimore, MD) announced that the firm's Managing Director, Robert Ferguson, will assume the position of President of the firm. Ferguson will assume all aspects of management and direction of the business from Thomas Weschler, who founded the company in 1996. // TG Therapeutics (New York, NY) appointed Adam Waldman as Chief Commercial Officer. // Hikma Pharmaceuticals (London, UK) appointed Henriette Nielsen to the newly created role of Chief Transformation Officer. // Ali Mortazavi stepped down as Chief Executive Officer and as a Director of the Silence Therapeutics (London, UK) after six years. Company Chair Dr. Annalisa Jenkins has assumed the role of Executive Chair in an interim capacity. //
Digital
Digital Transformation: What's the Cost of Doing Nothing?
Right now, the smartest incumbents are channeling the forces of disruption to their own ends, leading digital transformation in order to avoid being left behind, writes Tony Owens
/Read more/
Advertisement
Patient Engagement in Clinical Trials
On Demand
Learn more
Digital
Digital Health: "It's Not About the App"
Digital health is not at all about the app. It's about the behavior of the individual patient, said Søren Smed Østergaard at this year's Digital Health World Congress in London
/Read more/
Advertisement
Capturing The Attention of Investors: How to create a compelling value story
On Demand
Learn more
Event
Attribution: Mission-Critical for Digital Marketing Measurement
Marc O' Connor discusses key insights from Asembia 2018
/Read more/
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com